Redefining success: predicting checkpoint inhibitor toxicity to improve patient outcomes
Immuno-Oncology Insights 2022; 3(6), 311–314
DOI: 10.18609/ioi.2022.030
Published: 13 June 2022
Viewpoint
Joanne Weidhaas
“Immunotherapy represents a new era in which
toxicity has become an incredibly important
consideration in treatment... harnessing
immunity can be very powerful, but can lead
to very severe sequelae and toxicity, and these
toxicities can be life ending.”